Page 13 - newsletter3GAPP

Recent Advantages per Area

For each deliverable generated, EAB provides a comprehensive expert feedback.

WP3
Contribution and collaboration of both associated and collaborative GAPP partners are a crucial
precondition for a successful evaluation.

INTEGRATION IN NATIONAL POLICIES AND SUSTAINABILITY
WP4 WP Coleaders: RNDVCSH, Romania and ISS-CNT-CNS, Italy

WP4 started in April 2020 and is conducted by the Registrul National al Donatorilor Voluntari de Celule
Stem Hematopoietice, from Romania with the support of the Italian National Institute of Health,
National Transplant and Blood centres. The Aim of WP4 is:
- To set up a plan to describe the potential of GAPP results for integration in policies (at national,
regional or local levels)
- To ensure the sustainability of the JA activities at national or local or regional level.
- Draft a common proposal for supporting a sustainable implementation in single countries.
The work will focus on implementation and thereby sustainability at two levels.
- At the CA level for regional/ national policies and eventually within Europe.
- At the professional level for acceptance and thereby integration into good practice at national/
European level.
A Swedish expert is supporting the activities of WP4 related to the implementation on national
legislation in cooperation with the Swedish tissue council (SALAR) collaborating stakeholder in the
action. A draft plan for the implementation of GAPP outcome in Sweden has been drafted in July 2020
and is presently ongoing.

DEVELOPMENT OF OVERALL GUIDANCE ON ORGANIZATION OF PPA SYSTEM

WP5 WP Leader: HPRA, Ireland; OCATT, Spain

WP5 has the objective of developing an overall guidance on how a preparation process authorisation
(PPA), should or could be organised. Two deliverables have been drafted and sent to the External
Advisory Board. D5.1, involves a review of the previous European projects to be applicable to blood
establishments. D5.2 contains a review of the outcome and conclusions of the survey that was sent
to the European Competent Authorities, it also includes a revision of a desk-based review of PPA in
other fields, and the conclusions of the two multi country-workshops that were held at the facilities of
the European Commission in October 2019, for Tissue and Cell CAs, and February 2020 for Blood CAs.
WP5 is currently designing the main contents and the structure of the Overall Guidance on Organisa-
tion of PPA system and it will be presented soon to the rest of the WPs’ leaders.

This brochure is part of the joint action ‘785269/GAPP’ which has received funding from the European Union’s 13
Health Programme (2014-2020) GAPP - Newsletter3